United Kingdom Archives

News and Trends 9 Nov 2015

Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer

Cell-based Immune-oncology therapies continue to deliver amazing results. After Cellectis wondersaving from last week, Oxford’s Adaptimmune has some surprisingly good results too. Adaptimmune is a British, Oxford-based immuno-oncolgy company. It held a massive IPO last year, raising up to €150M on the NASDAQ, and its CEO was interviewed by BIO (video here) where he seemed […]

November 9, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 6 Nov 2015

Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?

About 30%. That’s how Cellectis‘ NASDAQ stock price has jumped between the 4th and the 5th of November. But why? Basically, because of the first human success of their allogeneic CAR-T therapy! The Great Ormond Street Hospital (UK) treated a young patient with refractory relapsed Acute Lymphoblastic Leukemia (ALL) with Cellectis’ allogeneic UCART19 product candidate in June. To […]

November 6, 2015 - 2 minutesmins - By Jerome Topsent

News and Trends 6 Nov 2015

Biotech of the Week: Synpromics, the Scottish company enabling precise Gene Expression

This week we leave the wonderful weather of Mallorca and head North, through France, England and across Hadrian’s Wall where we land in the capital city of Scotland, Edinburgh. This city is famous for many things, being one of the most haunted cities in the world to being built on an extinct volcano however, it […]

November 6, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 5 Nov 2015

Living Buildings ‘Self-Heal’ in the UK with Calcium Carbonate Secreting Bacteria

Using Biotech to make living, self-sustaining buildings is a new level of innovation which could revolutionize construction engineering. The ‘Materials For Life‘ Project in Wales (UK) is literally producing stones which self-repair and resist erosion! The University of Cardiff (Wales) leads a team with the University of Bath (SW England) and the University of Cambridge […]

November 5, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 3 Nov 2015

Exclusive from BIO-Europe 2015: Interview with F-star, a Cambridge-UK Immuno-oncology Biotech

Second interview of BIO-Europe 2015. This time, it’s a British company from Cambridge (UK): F-star. This morning we spoke with their CBO Jane Dancer. F-star is developing bi-specific antibodies for immuno-oncology and inflammatory disease. It has raised a total of 38 million euros from top EU VCs. Jane Dancer’s business tenure within the field is […]

November 3, 2015 - 1 minutemin - By Philip Hemme

News and Trends 3 Nov 2015

History of Biotech: 25 Years of The Human Genome Project

The birth of the Human Genome Project was now 25 years ago (woah!)…What was the HGP’s significance to biotech? What? The Human Genome Project (HGP) was an international effort with a primary goal; to sequence the entire genetic code of a whole organism (Humans…). It today remains the largest ever world collaborative project, which thrust the […]

November 3, 2015 - 5 minutesmins - By Marie Godar

News and Trends 30 Oct 2015

Purple GMO Tomatoes are Growing Medicines in the UK

Meet the purple tomatoes which produce as much Revervesterol in a single fruit as 50 bottles of wine, and as much anti-breast cancer chemical as 2.5Kg of Tofu! The John Innes Centre in Norwich (East England) have engineered these tomato plants to produce larger amounts of these health-related compounds. With funding from the Biotechnology and […]

October 30, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Oct 2015

Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome

We still haven’t fully sequenced the domestic wheat genome! Now the US Dragen chip has the answer for speedy whole-genome analysis, which The Genome Analysis Centre (TGAC) in England will test out for UK food-security research. Dragen is a Bio-IT platform processing chip which has clinical pipelines for many areas in research, including the Microbiome, […]

October 28, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Oct 2015

The Cambridge Gene-Editing Biotech Success Story: Horizon Discovery is Doubling in Size with new HQ

Horizon Discovery is a gene-editing tools specialist with various biotech partnerships over their cell-line catalogues. A UK expansion for Horizon is now underway, with the launch of a new genomics eCommerce webshop and the expansion of their headquarters. Horizon Discovery provides personalized translational medicine products and services, such as bespoke cell-lines for drug discovery and […]

October 28, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Oct 2015

Fighting Infection with a Pioneering Arsenal of Med-Tech Inventions from the UK

Bath, in South West England, has a lot more besides its historic beauty…The Jenkins Chemistry lab at the University of Bath has a fair few innovative solutions to the problem of infectious disease detection. Their latest design is a burns dressing which glows when a pathogenic biofilm is detected (as part of the Bacteriosafe Project) […]

October 28, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 26 Oct 2015

Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal

CRIPSR’s hype is not going down yet. CRIPSR/Cas9 or Cpf1 is a revolutionising gene editing tool, which almost won the Nobel Prize of this year (it won nearly all the other biology prizes already). It also caught great interest from the industry and venture capitalists. The leading Biotechs includes: Editas, Boston-based and clozed a $120M found […]

October 26, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 26 Oct 2015

Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue!

The fight against Alzheimer‘s with the World Health Organization and the G8 Dementia Summit rallies a collective of biotech industry specialists also wanting in on the battle front. The latest development in the Dementia Discovery Fund (DDF) includes US Biogen‘s dramatic cuts to redirect $250M into the Neurodegenerative disease venture, and investment into $100M ‘A’ […]

October 26, 2015 - 3 minutesmins - By Dani Bancroft

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer

Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?

Biotech of the Week: Synpromics, the Scottish company enabling precise Gene Expression

Living Buildings ‘Self-Heal’ in the UK with Calcium Carbonate Secreting Bacteria

Exclusive from BIO-Europe 2015: Interview with F-star, a Cambridge-UK Immuno-oncology Biotech

History of Biotech: 25 Years of The Human Genome Project

Purple GMO Tomatoes are Growing Medicines in the UK

Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome

The Cambridge Gene-Editing Biotech Success Story: Horizon Discovery is Doubling in Size with new HQ

Fighting Infection with a Pioneering Arsenal of Med-Tech Inventions from the UK

Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal

Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue!

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!